The MHRA is consulting on whether it should recognise CE-marked medical devices in Britain indefinitely to minimise the risk of supply disruption. 

A consultation on proposals for indefinite recognition of CE-marked medical devices in Great Britain has been welcomed. 

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is consulting on whether it should recognise CE-marked medical devices in Britain indefinitely. 

As the law currently stands, general medical devices compliant with the EU medical devices directive (EU MDD) or EU active implantable medical devices directive (EU AIMDD) with a valid declaration and CE marking can be placed on the GB market up until the sooner of expiry of certificate or 30 June, 2028. 

In vitro diagnostic medical devices (IVDs) compliant with the EU in vitro diagnostic medical devices directive (EU IVDD) can be placed on the GB market up until the expiry of the certificate or 30 June, 2030, and general medical devices, including custom-made devices, compliant with the EU medical devices regulation (EU MDR) and IVDs compliant with the EU in vitro diagnostic medical devices regulation (EU IVDR) can be placed on the GB market up until the same date. 

Risk of disruption

The MHRA is inviting views that extend the current transitional arrangements for devices that comply with the Medical Device Directive (MDD) to align with the EU timelines for devices to transition from MDD to EU Medical Devices Regulation. 

It is also considering indefinitely recognising devices that comply with the EU Medical Device Regulation (EU MDR) and EU in vitro Diagnostic Medical Devices Regulation (EU IVDR), and introducing an international reliance route for devices classified higher in Great Britain than in the EU. 

The regulator said 90% of medical devices used in the UK are CE-marked, which indicates compliance with EU health and safety standards. 

The thinking behind the legislation is to minimise the risk of supply disruption and to reduce the risk of interruption to the supply of medical devices for patients in Britain. 

“If the UK healthcare system is to benefit from the innovation that medical device manufacturers can deliver, it makes sense for Britain to form a closer regulatory relationship with the EU,” said Gerard Hanratty, head of health and life sciences at law firm Browne Jacobson. 

“The size of the EU market means the UK could risk falling behind European countries in adopting the latest medtech innovations by running two separate regulatory regimes,” he added.